Please login to the form below

Not currently logged in
Email:
Password:

Sanofi looks to mobile data to power behavioural analysis

Teams up with Evidation Health for a new digital health partnership

wearables

Sanofi has teamed up with US tech firm Evidation Health to tap into its behavioural data analysis platform, Real Life Study, for work that will be powered with data collected from wearables and mobile applications.

The three-year partnership aims to increase Sanofi’s understanding of disease burden and develop solutions from the data that will improve therapeutic outcomes.

Christine Lemke, co-founder and president of Evidation Health, said: “Consumers are sharing their digital footprint through wearables, sensors and apps, and we need to listen so we can better help them navigate their day-to-day health journey.”

According to a national survey conducted by Rock Health, 46% of US consumers were considered active digital health adopters, with 24% owning a wearable and 22% actively tracking at least one key health factor via a mobile application.

Digitally analysing patient behaviours can play a ‘significant’ role in patient outcomes and can even predict how likely it is for an individual to get ill, according to Evidation.

Heather Bell, senior vice president and global head of digital and analytics at Sanofi, said: “Working closely with Evidation and its distinctive analytics platform will help us better understand the factors that affect patient outcomes.

“We can then use those insights to support patients and healthcare professionals in managing disease and delivering the most value from our therapies.”

The duo previously worked together to identify behavioural markets that could improve treatment adherence and guide positive lifestyle change in patients with type 2 diabetes.

Lemke added: “By partnering with Sanofi’s innovative team, we have an opportunity to better manage population health in the digital era by illuminating underlying health behaviours in a privacy-safe and patient-permissioned way.”

Article by
Gemma Jones

31st August 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics